Difference between revisions of "Sertraline-mianserine"
From Psychiatrienet
(Created page with '{{Drugswitch | from = sertraline | to = mianserine | stop = * Gradually reduce dosage of sertraline to a maximum of 50 mg/ day, when this dosage is > 50 mg/day. | start = ...') |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 3: | Line 3: | ||
| to = mianserine | | to = mianserine | ||
| stop = | | stop = | ||
| − | * | + | * '''Before day 1:''' gradually reduce dosage of sertraline to a maximum of 50 mg/ day, when this dosage is > 50 mg/day. |
| + | * '''Day 1:''' reduce dosage of sertraline to 25 mg/day. | ||
| start = | | start = | ||
| − | * '''Day 1:''' | + | * '''Day 1:''' simultaneously start administration of mianserine in a low dosage of 30 mg/day for one week. |
| − | * '''Day 8:''' stop administration of sertraline and continue administration of | + | * '''Day 8:''' stop administration of sertraline and continue administration of mianserine only. }} |
Latest revision as of 16:08, 20 November 2009
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Switch medication from sertraline to mianserine.[1] [2]
Stop sertraline - Before day 1: gradually reduce dosage of sertraline to a maximum of 50 mg/ day, when this dosage is > 50 mg/day.
- Day 1: reduce dosage of sertraline to 25 mg/day.
Start mianserine- Day 1: simultaneously start administration of mianserine in a low dosage of 30 mg/day for one week.
- Day 8: stop administration of sertraline and continue administration of mianserine only.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
